What Researchers Did
Researchers reviewed the scientific evidence and clinical applications of hyperbaric oxygen (HBO) therapy for compromised tissue grafts and flaps.
What They Found
They found that hyperbaric oxygen (HBO) therapy maximizes viability and reduces the need for repeat grafting in compromised grafts, and attenuates ischemic and reperfusion injury in compromised flaps. HBO promotes hyper-oxygenation, fibroblast proliferation, collagen deposition, angiogenesis, and vasculogenesis, with animal studies demonstrating increased blood vessel growth and clinical studies showing positive responses in various tissue types.
What This Means for Canadian Patients
Canadian patients undergoing tissue grafting or flap procedures could benefit from hyperbaric oxygen (HBO) therapy if their tissues become compromised, potentially improving outcomes and reducing the need for repeat surgeries. Early recognition of tissue compromise and prompt initiation of HBO treatment are critical to maximize the chance of tissue survival.
Canadian Relevance
This study does not have a direct Canadian connection as it was not conducted in Canada, nor does it specifically mention Canadian patients or healthcare systems.
Study Limitations
This review synthesizes existing literature without providing a quantitative meta-analysis or addressing potential heterogeneity among the included studies.